CRLF2 and lymphoid leukemia: Given that the regulatory element of P2RY8 is highly active in lymphoid cells, it is fitting that the P2RY8-CRLF2 rearrangement, which places the proto-oncogenic CRLF2 under control of the P2RY8 regulatory element, is correlated with lymphoid leukemia.